We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$38.3B
AUM Growth
-$2.87B
Cap. Flow
-$3.32B
Cap. Flow %
-8.66%
Top 10 Hldgs %
40.1%
Holding
738
New
76
Increased
139
Reduced
316
Closed
180

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$301M
2
JPM icon
JPMorgan Chase
JPM
+$284M
3
WFC icon
Wells Fargo
WFC
+$279M
4
PM icon
Philip Morris
PM
+$224M
5
CSCO icon
Cisco
CSCO
+$185M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$630M
2
CVX icon
Chevron
CVX
+$444M
3
KO icon
Coca-Cola
KO
+$414M
4
MRK icon
Merck
MRK
+$388M
5
PEP icon
PepsiCo
PEP
+$341M

Sector Composition

Rank Sector Weight
1 Technology 27.22%
2 Healthcare 20.79%
3 Consumer Staples 19.28%
4 Communication Services 6.05%
5 Industrials 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMC
26
DELISTED
EMC CORPORATION
EMC
$372M 0.97%
13,581,132
+2,926,810
+27% +$76.1M
EMR icon
27
Emerson Electric
EMR
$82.9B
$328M 0.85%
4,902,860
+1,772,919
+57% +$117M
EBAY icon
28
eBay
EBAY
$48.6B
$324M 0.85%
13,939,971
+4,048,600
+41% +$94M
NKE icon
29
Nike
NKE
$61.9B
$312M 0.81%
8,460,130
-162,526
-2% -$6.14M
RTX icon
30
RTX Corp
RTX
$287B
$306M 0.8%
4,154,965
-98
-0% -$7.04K
LLY icon
31
Eli Lilly
LLY
$1.07T
$301M 0.78%
5,110,724
-1,192,120
-19% -$66.5M
ACN icon
32
Accenture
ACN
$89.9B
$294M 0.77%
3,684,577
+1,201,409
+48% +$98.7M
HPQ icon
33
HP
HPQ
$23.5B
$274M 0.72%
18,677,553
-14,047,131
-43% -$189M
BAX icon
34
Baxter International
BAX
$11.6B
$259M 0.68%
6,482,816
+1,107,247
+21% +$41.4M
DHR icon
35
Danaher
DHR
$135B
$253M 0.66%
5,010,902
+1,493,852
+42% +$76M
MON
36
DELISTED
Monsanto Co
MON
$240M 0.63%
2,111,956
+1,182,327
+127% +$132M
PFE icon
37
Pfizer
PFE
$140B
$217M 0.56%
7,105,857
-21,145,378
-75% -$630M
BMY icon
38
Bristol-Myers Squibb
BMY
$127B
$215M 0.56%
4,144,419
-4,795,438
-54% -$255M
COST icon
39
Costco
COST
$415B
$205M 0.54%
1,839,788
+103,027
+6% +$11.8M
SYK icon
40
Stryker
SYK
$127B
$201M 0.53%
2,472,702
-164,020
-6% -$13M
ELV icon
41
Elevance Health
ELV
$81.9B
$197M 0.51%
1,981,566
+367,722
+23% +$33.3M
BDX icon
42
Becton Dickinson
BDX
$43.1B
$190M 0.5%
1,662,548
-112,833
-6% -$12.4M
CPA icon
43
Copa Holdings
CPA
$5.56B
$186M 0.49%
1,281,061
-112,863
-8% -$15.7M
ITW icon
44
Illinois Tool Works
ITW
$81.4B
$185M 0.48%
2,271,534
+867,306
+62% +$70.2M
EEM icon
45
iShares MSCI Emerging Markets ETF
EEM
$28.5B
$176M 0.46%
4,287,735
+1,082,296
+34% +$42.5M
SYY icon
46
Sysco
SYY
$39.7B
$172M 0.45%
4,755,591
-629,219
-12% -$22.6M
ZBH icon
47
Zimmer Biomet
ZBH
$17.7B
$164M 0.43%
1,784,777
-571,778
-24% -$52.7M
BBBY
48
DELISTED
Bed Bath & Beyond Inc
BBBY
$163M 0.43%
2,368,849
+1,122,873
+90% +$76M
COV
49
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$155M 0.4%
2,103,588
+879,497
+72% +$61.3M
CTSH icon
50
Cognizant
CTSH
$21.5B
$150M 0.39%
2,969,710
+1,247,774
+72% +$62.4M
1
2
3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2014 Portfolio in Review

As of Q1 2014, Grantham, Mayo, Van Otterloo & Co (GMO) held 738 positions worth $38.3B, down 7% from $41.2B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $3.32B in Q1 2014, closing 180 positions and reducing 316 holdings. Its most notable exit was BROOKFIELD OFFICE PROPERTIES. INC, an estimated $37.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Xilinx Inc worth $58.7M.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2014 buy was Xilinx Inc: 1,081,003 shares worth $58.7M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Apple in Q1 2014, an estimated $301M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2014 reduction was Pfizer, cutting an estimated $630M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited BROOKFIELD OFFICE PROPERTIES. INC in Q1 2014, selling an estimated $37.7M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $38.3B portfolio in Q1 2014.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 76 new positions and closed 180 in Q1 2014.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 7% quarter-over-quarter to $38.3B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2014, filed 14 May 2014.